Results
|
1801.
|
|
|
1802.
|
A combined DNA-affinic molecule and N-mustard alkylating agent has an anti-cancer effect and induces autophagy in oral cancer cells. [electronic resource] by
- Lo, Wen-Liang
- Chu, Pen-Yuan
- Lee, Tsung-Heng
- Su, Tsann-Long
- Chien, Yueh
- Chen, Yi-Wei
- Huang, Pin-I
- Tseng, Ling-Ming
- Tu, Pang-Hsien
- Kao, Shou-Yen
- Lo, Jeng-Fan
Producer: 20150901
In:
International journal of molecular sciences vol. 13
Availability: No items available.
|
|
1803.
|
|
|
1804.
|
|
|
1805.
|
|
|
1806.
|
|
|
1807.
|
|
|
1808.
|
|
|
1809.
|
|
|
1810.
|
Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53. [electronic resource] by
- Gadhikar, Mayur A
- Sciuto, Maria Rita
- Alves, Marcus Vinicius Ortega
- Pickering, Curtis R
- Osman, Abdullah A
- Neskey, David M
- Zhao, Mei
- Fitzgerald, Alison L
- Myers, Jeffrey N
- Frederick, Mitchell J
Producer: 20140401
In:
Molecular cancer therapeutics vol. 12
Availability: No items available.
|
|
1811.
|
|
|
1812.
|
|
|
1813.
|
|
|
1814.
|
ZEB1 inhibition sensitizes cells to the ATR inhibitor VE-821 by abrogating epithelial-mesenchymal transition and enhancing DNA damage. [electronic resource] by
- Song, Na
- Jing, Wei
- Li, Ce
- Bai, Ming
- Cheng, Yu
- Li, Heming
- Hou, Kezuo
- Li, Yanrong
- Wang, Kai
- Li, Zhi
- Liu, Yunpeng
- Qu, Xiujuan
- Che, Xiaofang
Producer: 20190917
In:
Cell cycle (Georgetown, Tex.) vol. 17
Availability: No items available.
|
|
1815.
|
Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancer. [electronic resource] by
- Li, Jian-Ang
- Song, Chao
- Rong, Yefei
- Kuang, Tiantao
- Wang, Dansong
- Xu, Xuefeng
- Yuan, Jian
- Luo, Kuntian
- Qin, Bo
- Nowsheen, Somaira
- Lou, Zhenkun
- Lou, Wenhui
Producer: 20190829
In:
Cell cycle (Georgetown, Tex.) vol. 17
Availability: No items available.
|
|
1816.
|
|
|
1817.
|
A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types. [electronic resource] by
- Dinkelborg, Patrick H
- Wang, Meng
- Gheorghiu, Liliana
- Gurski, Joseph M
- Hong, Theodore S
- Benes, Cyril H
- Juric, Dejan
- Jimenez, Rachel B
- Borgmann, Kerstin
- Willers, Henning
Producer: 20190716
In:
Breast cancer research and treatment vol. 174
Availability: No items available.
|
|
1818.
|
|
|
1819.
|
|
|
1820.
|
DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer. [electronic resource] by
- Meng, Yunxiao
- Chen, Chi-Wei
- Yung, Mingo M H
- Sun, Wei
- Sun, Jing
- Li, Zhuqing
- Li, Jing
- Li, Zongzhu
- Zhou, Wei
- Liu, Stephanie S
- Cheung, Annie N Y
- Ngan, Hextan Y S
- Braisted, John C
- Kai, Yan
- Peng, Weiqun
- Tzatsos, Alexandros
- Li, Yiliang
- Dai, Zhijun
- Zheng, Wei
- Chan, David W
- Zhu, Wenge
Producer: 20190805
In:
Cancer letters vol. 428
Availability: No items available.
|